Florida Cancer Specialists & Research Institute Launches FCS Hematology Oncology Review

Florida Cancer Specialists & Research Institute launched a new website, Florida Cancer Specialists Hematology Oncology Review (FCSHemOncReview.com), to host a variety of top articles ranging from recent oncology and hematology studies to new therapies, even topics on value-based care.

As the world of oncology is ever-changing, it is the duty of our physicians to be informed of new and upcoming treatments as they come available, not only within the studies conducted at Florida Cancer Specialists & Research Institute, but throughout the world, and to share those amongst peers. And so, the creation of the Florida Cancer Specialists & Research Institute Hematology Oncology Review presents an innovative mode of distribution, collaboration, and sharing of this time-sensitive information that so greatly impacts the quality of care and outcomes of our patients.

The site, intended primarily for providers, will feature a mixture of articles from across the world, including studies from the Florida Cancer Specialists & Research Institute clinical research team. The functionality allows visitors to conduct high-level searches, comment on articles, and even share digitally. Visitors are encouraged to return frequently as new articles are posted throughout each month.

“Our patients and our peers rely on us for deep knowledge and understanding of the latest advances in medicine, especially as they pertain to hematology and oncology,” says Florida Cancer Specialists & Research Institute Chief Medical Officer of Therapeutics and Analytics Lucio Gordan, MD. “This website will make it much easier for our colleagues and peers to observe the newest treatments available and relay those to our patients.”

“Florida Cancer Specialists & Research Institute prides itself on being a leader in the oncology space. Our physicians are deeply invested in progressing cancer care and by creating this site, we are able to provide an excellent conduit for sharing of information, ensuring that our patients continue to get nothing less than the best standard of care,” says Florida Cancer Specialists & Research Institute Chief Executive Officer Nathan H. Walcker.